Global Partners LP (GLP)
NYSE: GLP · Real-Time Price · USD
50.21
+0.71 (1.43%)
Aug 8, 2025, 4:00 PM - Market closed

Revance Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
17,82817,16416,49218,87813,2488,322
Upgrade
Revenue Growth (YoY)
3.74%4.07%-12.64%42.49%59.20%-36.39%
Upgrade
Cost of Revenue
16,70116,06215,47417,73512,4877,553
Upgrade
Gross Profit
1,1261,1021,0191,143761.7768.84
Upgrade
Selling, General & Admin
869.76851.15769.26750.71608.9563.53
Upgrade
Operating Expenses
876.97859.43777.39759.56619.61574.37
Upgrade
Operating Income
249.27242.22241.14383.22142.09194.47
Upgrade
Interest Expense
-140.11-134.77-85.63-81.26-80.09-83.54
Upgrade
Earnings From Equity Investments
2.63-1.512.5---
Upgrade
EBT Excluding Unusual Items
111.78105.93158.02301.9662.01110.93
Upgrade
Merger & Restructuring Charges
----2.8--
Upgrade
Gain (Loss) on Sale of Assets
8.919.492.6379.870.51-0.28
Upgrade
Asset Writedown
-0.7-0.49---0.38-1.93
Upgrade
Other Unusual Items
-2.8-2.63----7.16
Upgrade
Pretax Income
117.2112.3160.64379.0362.13101.56
Upgrade
Income Tax Expense
3.524.618.1416.821.34-0.12
Upgrade
Earnings From Continuing Operations
113.67107.69152.51362.2160.8101.68
Upgrade
Minority Interest in Earnings
-17.43-15.34-9.91-7.14-3.58-0.87
Upgrade
Net Income
96.2492.35142.6355.0757.22100.81
Upgrade
Preferred Dividends & Other Adjustments
7.129.5814.5613.8512.216.73
Upgrade
Net Income to Common
89.1282.77128.04341.2245.0194.08
Upgrade
Net Income Growth
-10.29%-35.24%-59.84%520.59%-43.24%192.31%
Upgrade
Shares Outstanding (Basic)
343434343434
Upgrade
Shares Outstanding (Diluted)
343434343434
Upgrade
Shares Change (YoY)
0.39%0.88%-0.01%-0.68%-0.09%-0.09%
Upgrade
EPS (Basic)
2.632.453.7710.061.332.77
Upgrade
EPS (Diluted)
2.602.413.7610.021.312.74
Upgrade
EPS Growth
-4.96%-35.90%-62.48%664.88%-52.19%238.27%
Upgrade
Free Cash Flow
250.57-286.78110.42373.2-51.5236.19
Upgrade
Free Cash Flow Per Share
7.30-8.353.2410.96-1.506.88
Upgrade
Dividend Per Share
2.9702.9002.7152.4602.3101.903
Upgrade
Dividend Growth
5.51%6.81%10.37%6.49%21.42%-8.09%
Upgrade
Gross Margin
6.32%6.42%6.18%6.05%5.75%9.24%
Upgrade
Operating Margin
1.40%1.41%1.46%2.03%1.07%2.34%
Upgrade
Profit Margin
0.50%0.48%0.78%1.81%0.34%1.13%
Upgrade
Free Cash Flow Margin
1.41%-1.67%0.67%1.98%-0.39%2.84%
Upgrade
EBITDA
393.23381.91351.23488.01244.33294.6
Upgrade
EBITDA Margin
2.21%2.23%2.13%2.58%1.84%3.54%
Upgrade
D&A For EBITDA
143.96139.69110.09104.8102.24100.14
Upgrade
EBIT
249.27242.22241.14383.22142.09194.47
Upgrade
EBIT Margin
1.40%1.41%1.46%2.03%1.07%2.34%
Upgrade
Effective Tax Rate
3.00%4.10%5.07%4.44%2.15%-
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q